Tandem Diabetes Care share price logo

Tandem Diabetes Care

NASDAQ: TNDM

Small Cap

$16.11

+0.43

(+2.78%)

as on

Tandem Diabetes Care Stock Performance

as on October 12, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $15.40
    $16.12
    downward going graph

    4.41%

    Downside

    0.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.26
    $29.65
    downward going graph

    23.90%

    Downside

    84.05%

    Upside

    downward going graph

Tandem Diabetes Care share price movements today

Previous Close
$15.68
Open
$15.64
Volume
1.2M
Market Cap
$1.1B
Day's Low - High
$15.40 - $16.12
52 Week Low - High
$12.26 - $29.65

Tandem Diabetes Care Historical Returns

1 Month Return
-5.84 %
3 Month Return
+ 4.54 %
1 Year Return
+ 15.07 %
3 Year Return
-2.66 %
5 Year Return
-87.64 %

Tandem Diabetes Care Stock Fundamentals & Key Indicators

Check Tandem Diabetes Care market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-0.9287

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.37%

PE Ratio (TTM)

-17.35

Industry PE ratio

-7.12

PEG Ratio

-0.16

EBITDA

-34.8M

Revenue (TTM)

1.0B

Profit Margin

56.01%

Return On Equity TTM

-45.97%

Tandem Diabetes Care vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tandem Diabetes Care with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.1B-87.64%-17.3556.01%0.00%
Buy$113.2B-28.02%21.6366.69%3.23%
Buy$49.1B-21.69%48.9777.98%0.00%
StrongBuy$172.3B-15.10%32.0356.80%2.49%
StrongBuy$105.6B5.18%28.4765.17%1.27%

Stock Returns calculator for Tandem Diabetes Care Stock including INR - Dollar returns

The Tandem Diabetes Care stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tandem Diabetes Care investment value today

Current value as on today

₹1,24,279

Returns

₹24,279

(+24.28%)

Returns from Tandem Diabetes Care Stock

₹15,071 (+15.07%)

Dollar Impact

₹9,208 (+9.21%)

Analyst Recommendation on Tandem Diabetes Care Stock

Based on 8 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 8 analysts, 50% of analysts recommend a 'BUY' rating for Tandem Diabetes Care. Average target price of $27.86

Tandem Diabetes Care Share Price Target

Get share price movements and forecasts by analysts on Tandem Diabetes Care.

What analysts predicted

42.18%UPSIDE

Target Price

$27.86

Current Price

$16.11

Analyzed by

8 Analysts

High

$40

Target

$27.86

Low

$16

Tandem Diabetes Care target price $27.86, a slight upside of 42.18% compared to current price of $16.11. According to 8 analysts rating.

Indian Investors' Interest in Tandem Diabetes Care Stock

Search interest for Tandem Diabetes Care Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Tandem Diabetes Care Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
191
221
363
282
234
240
249
290
247
254
Gross Profit
94
112
124
157
118
125
134
167
136
144
Operating Income
-41
-30
-26
0
-120
-51
-20
8
-17
-13
EBITDA
-34
-23
-16
6
-116
-50
-18
11
-13
-13
Interest Expense
1
1
1
1
1
2
2
2
1
2
Depreciation
4
4
4
4
4
4
4
4
4
4
Income Before Tax
-39
-29
-22
0
-122
-57
-25
4
-19
-20
Income Tax Expense
3
1
0
0
8
-5
-3
5
0
0
Net Income
-42
-30
-23
0
-130
-52
-21
0
-20
-21
Net Profit Margin
49.39%
50.83%
34.31%
55.71%
50.51%
52.29%
53.88%
57.67%
55.33%
56.87%

Tandem Diabetes Care Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
107
183
362
498
702
801
747
940
1,014
Gross Profit
44
89
194
260
376
412
367
489
530
Operating Income
-62
-44
-16
-7
22
-92
-233
-99
-78
EBITDA
-54
-109
-18
-13
34
-74
-196
-82
-174
Interest Expense
11
7
0
12
6
6
9
7
7
Depreciation
6
5
6
10
13
14
15
16
17
Income Before Tax
-73
-122
-24
-36
15
-92
-220
-91
-200
Income Tax Expense
0
0
0
-1
0
1
2
4
4
Net Income
-73
-122
-24
-34
15
-94
-222
-96
-204
Net Profit Margin
40.98%
48.85%
53.60%
52.23%
53.53%
51.54%
49.17%
52.07%
52.31%

Tandem Diabetes Care Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-42
-30
-23
0
-130
-52
-21
0
-20
-21
Operating Cash Flow
-7
-5
26
10
-18
-9
8
9
11
-34
Investing Cash Flow
-5
-3
-19
5
9
58
20
-14
-195
-87
Financing Cash Flow
13
-3
-4
2
-4
-39
-1
2
274
2
Change in Cash
0
-11
1
20
-15
10
27
-1
88
-116

Tandem Diabetes Care Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
-122
-24
-34
15
-94
-222
-96
-204
Operating Cash Flow
-66
-8
41
24
111
50
-31
24
-9
Investing Cash Flow
2
-90
-56
-296
-186
33
-85
-23
72
Financing Cash Flow
32
117
24
314
51
16
4
8
-43
Change in Cash
-30
18
9
43
-23
101
-113
10
21

Global Institutional Holdings in Tandem Diabetes Care

Check out the Institutions with significant holdings in Tandem Diabetes Care.

Funds
Holdings
iShares
11.54%
Vanguard
9.55%
VANGUARD INDEX FUNDS
7.72%
Richard Driehaus
2.57%
SPDR
2.10%

Tandem Diabetes Care News & Key Events

  • img

    Today's Timeline - 07 July

    Tue, 11:23 AM

    -

    Tandem Diabetes receives CE mark for expanded indications for insulin delivery systems in Europe, enhancing its market position.

    Tue, 07:26 PM

    -

    Tandem Diabetes Care poised for growth with new reimbursement model; however, macroeconomic pressures may impact performance.

Insights on Tandem Diabetes Care

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TNDM stock has moved up by 4.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 247.22M → 254.56M (in $), with an average increase of 2.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Medtronic plc has given 21.9% return, outperforming this stock by 24.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 15.2% return, outperforming this stock by 0.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -589.0K → -21.16M (in $), with an average decrease of 1683.1% per quarter

About Tandem Diabetes Care

Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
OrganisationTandem Diabetes Care
Headquarters12400 High Bluff Drive, San Diego, CA, 92130, US
IndustryMedical - Devices
CEOJohn F. Sheridan

Key Management of Tandem Diabetes Care

Name

Title

Mr. Rick A. Carpenter

Executive VP & CTO

Ms. Susan M. Morrison

Executive VP & Chief Administrative Officer

Mr. John F. Sheridan

President, CEO & Director

Ms. Leigh A. Vosseller

Executive VP, CFO & Treasurer

Ms. Shannon M. Hansen J.D.

Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary

Ms. Elizabeth Anne Gasser

Executive VP and Chief Strategy & Product Officer

Mr. Jean-Claude E. Kyrillos

Executive VP & COO

Mr. Tom Fox

Executive VP & Chief Human Resources Officer

Dr. Jordan Pinsker M.D.

Chief Medical Officer

FAQs

What is Tandem Diabetes Care share price today?

Tandem Diabetes Care share price today is $16.11 as on at the close of the market. Tandem Diabetes Care share today touched a day high of $16.12 and a low of $15.40.

What is the 52 week high and 52 week low for Tandem Diabetes Care share?

Tandem Diabetes Care share touched a 52 week high of $29.65 on and a 52 week low of $12.26 on . Tandem Diabetes Care stock price today i.e. is closed at $16.11,which is 45.67% down from its 52 week high and 31.40% up from its 52 week low.

What is Tandem Diabetes Care's market capitalisation today?

Tandem Diabetes Care market capitalisation is $0.00T as on .

How to invest in Tandem Diabetes Care Stock (TNDM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tandem Diabetes Care on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Tandem Diabetes Care Stock (TNDM) from India?

Indian investors can start investing in Tandem Diabetes Care (TNDM) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Tandem Diabetes Care stock (as per the Rupee-Dollar exchange rate as on ). Based on Tandem Diabetes Care share’s latest price of $16.11 as on October 12, 2026 at 8:45 am IST, you will get 0.6207 shares of Tandem Diabetes Care. Learn more about fractional shares .

What are the returns that Tandem Diabetes Care has given to Indian investors in the last 5 years?

Tandem Diabetes Care stock has given -87.64% share price returns and 28.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?